FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster.
The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website.
By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser .
Research Articles Abstract - 2010 Issues Archive
Research Articles Abstract - May 10 2010 Issue
Research Articles Abstract - May 10 2010 Issue
[Source: US National Library of Medicine (
LINK ). Edited.]
Research Articles Abstract - May 10 2010 Issue
Campbell AP, Jacob ST, Kuypers J, Wald A, et al.
Respiratory failure caused by 2009 novel influenza A/H1N1 in a hematopoietic stem-cell transplant recipient: Detection of extrapulmonary H1N1 RNA and use of intravenous peramivir.
Ann Intern Med. 2010;152:619-20.
PubMed
Lee N, Chan PK, Lam WY, Szeto CC, et al.
Co-infection with pandemic H1N1 and seasonal H3N2 influenza viruses.
Ann Intern Med. 2010;152:618-9.
PubMed
Sharshov K, Romanovskaya A, Uzhachenko R, Durymanov A, et al.
Genetic and biological characterization of avian influenza H5N1 viruses isolated from wild birds and poultry in Western Siberia.
Arch Virol. 2010.
PubMed Abstract available
Randall TD.
Pulmonary dendritic cells: thinking globally, acting locally.
J Exp Med. 2010;207:451-4.
PubMed Abstract available
Wu W, Booth JL, Duggan ES, Patel KB, et al.
Human lung innate immune cytokine response to adenovirus type 7.
J Gen Virol. 2010;91.
PubMed Abstract available
Herd KA, Nelson M, Mahalingam S, Tindle RW, et al.
Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus.
J Gen Virol. 2010;91.
PubMed Abstract available
Cornberg M, Clute SC, Watkin LB, Saccoccio FM, et al.
CD8 T Cell Cross-Reactivity Networks Mediate Heterologous Immunity in Human EBV and Murine Vaccinia Virus Infections.
J Immunol. 2010.
PubMed Abstract available
Erden I, Erden EC, Ozhan H, Basar C, et al.
Echocardiographic manifestations of pandemic 2009 (h1n1) influenza a virus infection.
J Infect. 2010.
PubMed Abstract available
Li R, Lim A, Phoon MC, Narasaraju T, et al.
Attenuated Bordetella pertussis protects against highly pathogenic influenza A viruses by dampening the cytokine storm.
J Virol. 2010.
PubMed Abstract available
Murcia PR, Baillie GJ, Daly J, Elton D, et al.
The intra- and inter-host evolutionary dynamics of equine influenza virus.
J Virol. 2010.
PubMed Abstract available
Hale BG, Steel J, Medina RA, Manicassamy B, et al.
Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein.
J Virol. 2010.
PubMed Abstract available
Harker JA, Lee DC, Yamaguchi Y, Wang B, et al.
Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection.
J Virol. 2010;84:5294-302.
PubMed Abstract available
Shabat MB, Meir R, Haddas R, Lapin E, et al.
Development of a Real-Time TaqMan RT-PCR Assay for the Detection of H9N2 Avian Influenza Viruses.
J Virol Methods. 2010.
PubMed Abstract available
Ducatez MF, Sonnberg S, Hall RJ, Peacey M, et al.
Genotyping assay for the identification of 2009-2010 pandemic and seasonal H1N1 influenza virus reassortants.
J Virol Methods. 2010.
PubMed Abstract available
Vester D, Lagoda A, Hoffmann D, Seitz C, et al.
Real-time RT-qPCR assay for the analysis of human influenza A virus transcription and replication dynamics.
J Virol Methods. 2010.
PubMed Abstract available
...
Licensure of a high-dose inactivated influenza vaccine for persons aged >or=65 years (Fluzone High-Dose) and guidance for use - United States, 2010.
MMWR Morb Mortal Wkly Rep. 2010;59:485-6.
PubMed Abstract available
...
Interim results: state-specific seasonal influenza vaccination coverage - United States, August 2009-January 2010.
MMWR Morb Mortal Wkly Rep. 2010;59:477-84.
PubMed Abstract available
Brownstein JS, Freifeld CC, Chan EH, Keller M, et al.
Information technology and global surveillance of cases of 2009 H1N1 influenza.
N Engl J Med. 2010;362:1731-5.
PubMed
Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, et al.
Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection.
N Engl J Med. 2010;362:1708-19.
PubMed
Grunwald C, Schulze K, Reichel A, Weiss VU, et al.
In situ assembly of macromolecular complexes triggered by light.
Proc Natl Acad Sci U S A. 2010;107:6146-51.
PubMed Abstract available
# Rehmani R, Memon JI.
Knowledge, attitudes and beliefs regarding influenza vaccination among healthcare workers in a Saudi hospital.
Vaccine. 2010.
PubMed Abstract available
Ansaldi F, Zancolli M, Paolo D, Montomoli E, et al.
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.
Vaccine. 2010.
PubMed Abstract available
Baaten BJ, Clarke B, Strong P, Hou S, et al.
Nasal mucosal administration of chitin microparticles boosts innate immunity against influenza A virus in the local pulmonary tissue.
Vaccine. 2010.
PubMed Abstract available
de Vries RP, de Vries E, Bosch BJ, de Groot RJ, et al.
The influenza A virus hemagglutinin glycosylation state affects receptor-binding specificity.
Virology. 2010.
PubMed Abstract available
-
-----
Research Articles Abstracts - May 16 2010 Issue
Research Articles Abstracts - May 16 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstracts - May 16 2010 Issue
Chen Y, Luo W, Wu WL, Fang Z, et al.
Humanized Antibodies with Broad-Spectrum Neutralization to Avian Influenza Virus H5N1. Antiviral Res. 2010.
PubMed Abstract available
Sweet M.
Australia suspends seasonal flu vaccination of young children. BMJ. 2010;340:c2419.
PubMed
Mayor S.
Hospital stays for young adults with flu shot up in England in 2009. BMJ. 2010;340:c2234.
PubMed
Fu YH, He JS, Wang XB, Zheng XX, et al.
A prime-boost vaccination strategy using attenuated Salmonella typhimurium and a replication-deficient recombinant adenovirus vector elicits protective immunity against human respiratory syncytial virus. Biochem Biophys Res Commun. 2010;395:87-92.
PubMed Abstract available
Williams CJ, Buchholz U.
Influence of household contacts on the effectiveness of face masks for preventing influenza in a healthcare setting: a comment on Cowling et al. (2010). Epidemiol Infect. 2010.
PubMed
Suzuki K, Okada H, Itoh T, Tada T, et al.
Phenotypes influencing transmissibility of highly pathogenic avian influenza viruses in chickens. J Gen Virol. 2010.
PubMed Abstract available
Shanks GD, Mackenzie A, McLaughlin R, Waller M, et al.
Mortality Risk Factors During the 1918-1919 Influenza Pandemic in the Australian Army. J Infect Dis. 2010.
PubMed Abstract available
Li Y, Lu X, Li J, Berube N, et al.
Genetic engineered, biarsenical labelled influenza virus allows visualization of viral NS1 protein in living cells. J Virol. 2010.
PubMed Abstract available
Chan WH, Ng AK, Robb NC, Lam MK, et al.
Functional analysis of influenza H5N1 nucleoprotein tail loop reveals amino acids that are crucial for oligomerization and ribonucleoprotein activities. J Virol. 2010.
PubMed Abstract available
Huang K, Bahl J, Fan XH, Vijaykrishna D, et al.
Establishment of an H6N2 influenza virus lineage in domestic ducks in southern China. J Virol. 2010.
PubMed Abstract available
Qin M, Wang DY, Huang F, Nie K, et al.
Detection of pandemic influenza A H1N1 virus by multiplex reverse transcription-PCR with a GeXP analyzer. J Virol Methods. 2010.
PubMed Abstract available
Furuse Y, Odagiri T, Okada T, Khandaker I, et al.
Differentiation of human influenza A viruses including the pandemic subtype H1N1/2009 by conventional multiplex PCR. J Virol Methods. 2010.
PubMed Abstract available
Walley T, Davidson P.
Research funding in a pandemic. Lancet. 2010;375:1063-5.
PubMed
Lau JT, Yeung NC, Choi KC, Cheng MY, et al.
Factors in association with acceptability of A/H1N1 vaccination during the influenza A/H1N1 pandemic phase in the Hong Kong general population. Vaccine. 2010.
PubMed Abstract available
Cohen SA, Ahmed S, Klassen AC, Agree EM, et al.
Childhood Hib vaccination and pneumonia and influenza burden in US seniors. Vaccine. 2010.
PubMed Abstract available
Blank DL, Bodansky DM, Forbes A, Garde E, et al.
Influenza vaccination of future healthcare workers: A cross-sectional study of uptake, knowledge and attitudes. Vaccine. 2010.
PubMed Abstract available
Wong LP, Sam IC.
Factors influencing the uptake of 2009 H1N1 influenza vaccine in a multiethnic Asian population. Vaccine. 2010.
PubMed Abstract available
Walter EB, Rajagopal S, Zhu Y, Neuzil KM, et al.
Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: Do children of all ages respond equally? Vaccine. 2010.
PubMed Abstract available
Hull HF.
LAIV efficacy in military recruits. Vaccine. 2010;28:2066.
PubMed
Dinh A, Lawrence C, Salomon J, Descatha A, et al.
Expected and unexpected adverse effects H1N1 vaccination for health care workers in a university hospital. Vaccine. 2009.
PubMed
Zhu H, Wang J, Wang P, Song W, et al.
Substitution of lysine at 627 position in PB2 protein does not change virulence of the 2009 pandemic H1N1 virus in mice. Virology. 2010;401:1-5.
PubMed Abstract available
-
------
Research Articles Abstract - May 22 2010 Issue
Research Articles Abstract - May 22 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstract - May 22 2010 Issue
Lai KY, Ng WY, Osburga Chan PK, Wong KF, et al.
High-dose N-acetylcysteine therapy for novel H1N1 influenza pneumonia. Ann Intern Med. 2010;152:687-8.
PubMed
Kumar P, Sood V, Vyas R, Gupta N, et al.
Potent inhibition of influenza virus replication with novel siRNA-chimeric-ribozyme constructs.
Antiviral Res. 2010.
PubMed Abstract available
Acedo L, Diez-Domingo J, Morano JA, Villanueva RJ, et al.
Mathematical modelling of respiratory syncytial virus (RSV): vaccination strategies and budget applications. Epidemiol Infect. 2010;138:853-60.
PubMed Abstract available
Cha W, Ma Y, Saif YM, Lee CW, et al.
Development of microsphere-based multiplex branched DNA assay for the detection and differentiation of avian influenza virus. J Clin Microbiol. 2010.
PubMed Abstract available
Ma W, Lager KM, Lekcharoensuk P, Ulery ES, et al.
Viral reassortment and transmission after coinfection of pigs with classical H1N1 and triple reassortant H3N2 swine influenza viruses. J Gen Virol. 2010.
PubMed Abstract available
Busquets N, Abad FX, Alba A, Dolz R, et al.
Persistence of highly pathogenic avian influenza virus (H7N1) in infected chicken: feather as a suitable sample for diagnosis. J Gen Virol. 2010.
PubMed Abstract available
Quan FS, Kim YC, Vunnava A, Yoo DG, et al.
Intradermal vaccination with influenza VLPs using microneedles induces protection superior to intramuscular immunization. J Virol. 2010.
PubMed Abstract available
Du N, Zhou J, Lin X, Zhang Y, et al.
Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses. J Virol. 2010.
PubMed Abstract available
Boon AC, Debeauchamp J, Krauss S, Rubrum A, et al.
Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 influenza mouse model. J Virol. 2010.
PubMed Abstract available
Steelfisher GK, Blendon RJ, Bekheit MM, Lubell K, et al.
The Public's Response to the 2009 H1N1 Influenza Pandemic. N Engl J Med. 2010.
PubMed
Partridge J, Kieny MP.
Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets. Vaccine. 2010.
PubMed Abstract available
Lee BY, Brown ST, Korch G, Cooley PC, et al.
A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic. Vaccine. 2010.
PubMed Abstract available
Yang CF, Belshe RB, Kemble G, Song E, et al.
Genetic sequence analysis of influenza viruses and illness severity in ill children previously vaccinated with live attenuated or inactivated influenza vaccine. Vaccine. 2010.
PubMed Abstract available
Wicker S, Rabenau HF.
The reluctance of nurses to get vaccinated against influenza. Vaccine. 2010.
PubMed
Virseda S, Restrepo MA, Arranz E, Magan-Tapia P, et al.
Seasonal and Pandemic A (H1N1) 2009 influenza vaccination coverage and attitudes among health-care workers in a Spanish University Hospital. Vaccine. 2010.
PubMed Abstract available
Pushko P, Kort T, Nathan M, Pearce MB, et al.
Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus. Vaccine. 2010.
PubMed Abstract available
Eggert D, Thomas C, Spackman E, Pritchard N, et al.
Characterization and efficacy determination of commercially available Central American H5N2 avian influenza vaccines for poultry. Vaccine. 2010.
PubMed Abstract available
-
------
Research Articles Abstracts - May 29 2010 Issue
Research Articles Abstracts - May 29 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstracts - May 29 2010 Issue
OOI PL, Lai FY, Low CL, Lin R, et al.
Clinical and molecular evidence for transmission of novel influenza A(H1N1/2009)on a commercial airplane. Arch Intern Med. 2010;170:913-5.
LINK
MILLER AC, Safi F, Hussain S, Subramanian RA, et al.
Novel influenza A(H1N1) virus among gravid admissions. Arch Intern Med. 2010;170:868-73.
ABSTRACT available
TANG JW, Tambyah PA, Lai FY, Lee HK, et al.
Differing symptom patterns in early pandemic vs seasonal influenza infections. Arch Intern Med. 2010;170:861-7.
ABSTRACT available
BAKER MG, Thornley CN, Mills C, Roberts S, et al.
Transmission of pandemic A/H1N1 2009 influenza on passenger aircraft: retrospective cohort study. BMJ. 2010;340:c2424.
ABSTRACT available
YANG P, Dongmei, Wang C, Tang C, et al.
Characterization of a highly pathogenic avian influenza H5N1 virus isolated from an ostrich. Biochem Biophys Res Commun. 2010.
ABSTRACT available
ANDRESEN DN, Kesson AM.
High Sensitivity of a Rapid Immunochromatographic Test for the Detection of Influenza A Virus 2009 H1N1 on Nasopharyngeal Aspirates from Young Children. J Clin Microbiol. 2010.
ABSTRACT available
HOSSAIN MJ, Perez S, Guo Z, Chen LM, et al.
Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assays. J Clin Microbiol. 2010.
ABSTRACT available
LAI JC, Chan WW, Kien F, Nicholls JM, et al.
Formation of virus-like particles from human cell lines exclusively expressing Influenza neuraminidase. J Gen Virol. 2010.
ABSTRACT available
GUO H, Topham DJ.
IL-22 production by pulmonary natural killer cells and the potential role of IL-22 during primary influenza infection. J Virol. 2010.
ABSTRACT available
CHEN GL, Lamirande EW, Yang CF, Jin H, et al.
EVALUATION OF REPLICATION AND CROSS-REACTIVE ANTIBODY RESPONSE OF H2 INFLUENZA SUBTYPE VIRUSES IN MICE AND FERRETS. J Virol. 2010.
ABSTRACT available
DE LUCAS S, Peredo J, Marion RM, Sanchez C, et al.
Human Staufen1 protein interacts with influenza virus ribonucleoproteins and is required for efficient virus multiplication. J Virol. 2010.
ABSTRACT available
LANGLEY WA, Bradley KC, Li ZN, Smith ME, et al.
Induction of neutralizing antibody responses to anthrax PA using influenza vectors: Implications for disparate immune system priming pathways. J Virol. 2010.
ABSTRACT available
TATE MD, Pickett DL, van Rooijen N, Brooks AG, et al.
The Critical Role of Airway Macrophages in Modulating Disease Severity During Influenza Virus Infection of Mice. J Virol. 2010.
ABSTRACT available
CILLONIZ C, Pantin-Jackwood MJ, Ni C, Goodman AG, et al.
Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection. J Virol. 2010.
ABSTRACT available
CHAKRAVARTHY KV, Bonoiu AC, Davis WG, Ranjan P, et al.
Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication. Proc Natl Acad Sci U S A. 2010.
ABSTRACT available
CALDER LJ, Wasilewski S, Berriman JA, Rosenthal PB, et al.
Structural organization of a filamentous influenza A virus. Proc Natl Acad Sci U S A. 2010.
ABSTRACT available
TAMURA SI.
Studies on the usefulness of intranasal inactivated influenza vaccines. Vaccine. 2010.
ABSTRACT available
PALMER LA, Rousculp MD, Johnston SS, Mahadevia PJ, et al.
Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study. Vaccine. 2010.
ABSTRACT available
MELIDOU A, Gioula G, Exindari M, Chatzidimitriou D, et al.
Molecular and phylogenetic analysis of the haemagglutinin gene of pandemic influenza H1N1 2009 viruses associated with severe and fatal infections. Virus Res. 2010.
ABSTRACT available
BROWN A, McSharry JJ, Weng Q, Driebe EM, et al.
An In Vitro System for Modeling Influenza A Virus Resistance under Drug Pressure. Antimicrob Agents Chemother. 2010.
ABSTRACT available
-
-----
Research Articles Abstracts - June 4 2010 Issue
Research Articles Abstracts - June 4 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstracts - June 4 2010 Issue
Waddington CS, Walker WT, Oeser C, Reiner A, et al.
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ. 2010;340:c2649.
PubMed Abstract available
Higgins AD, Shaw CJ, Johnson JG, Navarro A, et al.
A Monoclonal Antibody Kit for Identification of the Novel 2009 H1N1 Influenza A Virus. J Clin Microbiol. 2010.
PubMed Abstract available
Robb N, Jackson D, Vreede F, Fodor E, et al.
Splicing of Influenza A Virus NS1 mRNA is Independent of the Viral NS1 Protein. J Gen Virol. 2010.
PubMed Abstract available
Shinya K, Makino A, Hatta M, Watanabe S, et al.
A mutation in H5 haemagglutinin that conferred human receptor recognition is not maintained stably during duck passage. J Gen Virol. 2010;91.
PubMed Abstract available
Stevens J, Chen LM, Carney PJ, Garten R, et al.
Receptor Specificity of Influenza A H3N2 Viruses Isolated in Mammalian Cells and Embryonated Chicken Eggs. J Virol. 2010.
PubMed Abstract available
Manz B, Matrosovich M, Bovin N, Schwemmle M, et al.
A polymorphism in the hemagglutinin of the human isolate of a highly pathogenic H5N1 influenza virus determines organ tropism in mice. J Virol. 2010.
PubMed Abstract available
Munster VJ, Schrauwen EJ, de Wit E, van den Brand JM, et al.
Insertion of a multi basic cleavage motif into the hemagglutinin of a low pathogenic avian influenza H6N1 virus induces a highly pathogenic phenotype. J Virol. 2010.
PubMed Abstract available
Oh HL, Akerstrom S, Shen S, Bereczky S, et al.
An antibody against a novel and conserved epitope in the HA1 subunit neutralizes numerous H5N1 influenza viruses. J Virol. 2010.
PubMed Abstract available
Seo YJ, Blake C, Alexander S, Hahm B, et al.
Sphingosine 1-phosphate-metabolizing enzymes control influenza virus propagation and viral cyto-pathogenicity. J Virol. 2010.
PubMed Abstract available
Gao Q, Lowen AC, Wang TT, Palese P, et al.
A nine-segmented influenza A virus carrying H1 and H3 subtype hemagglutinins. J Virol. 2010.
PubMed Abstract available
Govorkova EA, Ilyushina NA, Marathe BM, McClaren JL, et al.
Competitive Fitness of Oseltamivir-Sensitive and -Resistant Highly Pathogenic H5N1 Influenza Viruses in a Ferret Model. J Virol. 2010.
PubMed Abstract available
Bodewes R, Kreijtz JH, van Amerongen G, Geelhoed-Mieras MM, et al.
A single immunization with CoVaccine HTTM-adjuvanted H5N1 influenza vaccine induces protective cellular and humoral immune responses in ferrets. J Virol. 2010.
PubMed Abstract available
Berkley JA, Munywoki P, Ngama M, Kazungu S, et al.
Viral etiology of severe pneumonia among Kenyan infants and children. JAMA. 2010;303:2051-7.
PubMed Abstract available
...
Preliminary Results: Surveillance for Guillain-Barre Syndrome After Receipt of Influenza A (H1N1) 2009 Monovalent Vaccine --- United States, 2009--2010. MMWR Morb Mortal Wkly Rep. 2010;59:657-61.
PubMed Abstract available
DeVincenzo J, Lambkin-Williams R, Wilkinson T, Cehelsky J, et al.
A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci U S A. 2010;107:8800-5.
PubMed Abstract available
Turner RB, Fuls JL, Rodgers ND.
Effectiveness of hand sanitizers with and without organic acids for removal of rhinovirus from hands. Antimicrob Agents Chemother. 2010;54:1363-4.
PubMed Abstract available
-
------
Research Articles Abstracts - June 11 2010 Issue
Research Articles Abstracts - June 11 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstracts - June 11 2010 Issue
Monteerarat Y, Sakabe S, Ngamurulert S, Srichatraphimuk S, et al.
Induction of TNF-alpha in human macrophages by avian and human influenza viruses. Arch Virol. 2010.
PubMed Abstract available
Voeten JT, Kiseleva IV, Glansbeek HL, Basten SM, et al.
Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model. Arch Virol. 2010.
PubMed Abstract available
Martinez M, Perez AM, DE LA Torre A, Iglesias I, et al.
Evaluating surveillance in wild birds by the application of risk assessment of avian influenza introduction into Spain. Epidemiol Infect. 2010.
PubMed Abstract available
Moscona A, Porotto M, Palmer S, Tai C, et al.
A Recombinant Sialidase Fusion Protein Effectively Inhibits Human Parainfluenza Viral Infection In Vitro and In Vivo. J Infect Dis. 2010.
PubMed Abstract available
Fang Y, Rowe T, Leon AJ, Banner D, et al.
Molecular Characterization of in vivo Adjuvant Activity in Influenza-Vaccinated Ferrets. J Virol. 2010.
PubMed Abstract available
Kirby T.
Jim Bishop: the Chief Medical Officer of Australia. Lancet. 2010;375:1517.
PubMed
Hall CB.
Respiratory syncytial virus in young children. Lancet. 2010;375:1500-2.
PubMed
Nair H, Nokes DJ, Gessner BD, Dherani M, et al.
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375:1545-55.
PubMed Abstract available
...
Deaths and Hospitalizations Related to 2009 Pandemic Influenza A (H1N1) --- Greece, May 2009--February 2010. MMWR Morb Mortal Wkly Rep. 2010;59:682-6.
PubMed Abstract available
Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, et al.
Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci U S A. 2010.
PubMed Abstract available
Lorieau JL, Louis JM, Bax A.
The complete influenza hemagglutinin fusion domain adopts a tight helical hairpin arrangement at the lipid:water interface. Proc Natl Acad Sci U S A. 2010.
PubMed Abstract available
Perez JT, Varble A, Sachidanandam R, Zlatev I, et al.
Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc Natl Acad Sci U S A. 2010.
PubMed Abstract available
Kim JK, Kayali G, Walker D, Forrest HL, et al.
Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry.
Proc Natl Acad Sci U S A. 2010.
PubMed Abstract available
-
-----
Research Articles Abstracts - June 18 2010 Issue
Research Articles Abstracts - June 18 2010 Issue
Research Articles Abstracts - June 18 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstracts - June 18 2010 Issue
Zarocostas J.
Swine flu pandemic review panel seeks access to confidential documents between WHO and drug companies. BMJ. 2010;340:c2792.
PubMed
Iglesias I, Perez AM, Sanchez-Vizcaino JM, Munoz MJ, et al.
Reproductive ratio for the local spread of highly pathogenic avian influenza in wild bird populations of Europe, 2005-2008. Epidemiol Infect. 2010.
PubMed Abstract available
Ajelli M, Merler S, Pugliese A, Rizzo C, et al.
Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy. Epidemiol Infect. 2010.
PubMed Abstract available
Sakai-Tagawa Y, Ozawa M, Tamura D, Le QM, et al.
Sensitivity of influenza rapid diagnostic tests to H5N1 and 2009 pandemic H1N1 viruses. J Clin Microbiol. 2010.
PubMed Abstract available
Zhang ZY, Du LN, Chen X, Zhao Y, et al.
Genetic variability of respiratory syncytial viruses (RSV) prevalent in Southwestern China from 2006 to 2009: emergence of subgroup B and A RSV as dominant strains. J Clin Microbiol. 2010;48:1201-7.
PubMed Abstract available
Chen J, Huang S, Chen Z.
Human cellular protein nucleoporin hNup98 interacts with influenza A virus NS2/NEP protein and over-expression of its GLFG repeat domain can inhibit virus propagation. J Gen Virol. 2010.
PubMed Abstract available
Sun X, Tse LV, Ferguson AD, Whittaker GR, et al.
Modifications to the hemagglutinin cleavage site control virulence of a neurotropic H1N1 influenza virus. J Virol. 2010.
PubMed Abstract available
Song L, Liu H, Gao S, Jiang W, et al.
Cellular MicroRNAs Inhibit Replication of the H1N1 Influenza A Virus in Infected Cells. J Virol. 2010.
PubMed Abstract available
Li Y, Shi J, Zhong G, Deng G, et al.
Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry and humans in China from 2004 to 2009. J Virol. 2010.
PubMed Abstract available
Graef KM, Vreede FT, Lau YF, McCall AW, et al.
The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with MAVS and inhibiting IFN-{beta} expression. J Virol. 2010.
PubMed Abstract available
Lau YF, Tang LH, McCall AW, Ooi EE, et al.
An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza vaccine with antigen-sparing effect in mice. J Virol. 2010.
PubMed Abstract available
Small PA Jr, Morris JG Jr.
Influenza vaccination of children and infection rates in the community. JAMA. 2010;303:2355-6.
PubMed
Goldkind SF, Sahin L, Gallauresi B.
Enrolling pregnant women in research--lessons from the H1N1 influenza pandemic. N Engl J Med. 2010;362:2241-3.
PubMed
Scull MA, Rice CM.
A big role for small RNAs in influenza virus replication. Proc Natl Acad Sci U S A. 2010.
PubMed
van der Weijden CP, Bredenoord AL, van Delden JJ.
The duty to treat in the context of an influenza pandemic. Vaccine. 2010.
PubMed Abstract available
Sy LS, Liu IL, Solano Z, Cheetham TC, et al.
Accuracy of influenza vaccination status in a computer-based immunization tracking system of a managed care organization. Vaccine. 2010.
PubMed Abstract available
Girard MP, Tam JS, Assossou OM, Kieny MP, et al.
The 2009 A (H1N1) influenza virus pandemic: A review. Vaccine. 2010.
PubMed Abstract available
Lau JT, Cai Y, Tsui HY, Choi KC, et al.
Prevalence of influenza vaccination and associated factors among pregnant women in Hong Kong. Vaccine. 2010.
PubMed Abstract available
Orellano PW, Reynoso JI, Carlino O, Uez O, et al.
Protection of trivalent inactivated influenza vaccine against hospitalizations among pandemic influenza A (H1N1) cases in Argentina. Vaccine. 2010.
PubMed Abstract available
Pu J, Wang J, Zhang Y, Fu G, et al.
Synergism of co-mutation of two amino acid residues in NS1 protein increases the pathogenicity of influenza virus in mice. Virus Res. 2010.
PubMed Abstract available
-
-----
Research Articles Abstracts - June 25 2010 Issue
Research Articles Abstracts - June 25 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstracts - June 25 2010 Issue
Qi T, Guo W, Huang WQ, Li HM, et al.
Genetic evolution of equine influenza viruses isolated in China. Arch Virol. 2010.
PubMed Abstract available
Moynihan R.
Australian government says healthy under 5s should not be given seasonal flu jab. BMJ. 2010;340:c2991.
PubMed
O'Dowd A.
Council of Europe condemns "unjustified scare" over swine flu. BMJ. 2010;340:c3033.
PubMed
Godlee F.
Conflicts of interest and pandemic flu. BMJ. 2010;340:c2947.
PubMed
Cohen D, Carter P.
Conflicts of interest. WHO and the pandemic flu "conspiracies". BMJ. 2010;340:c2912.
PubMed
Doyle TJ, Hopkins RS.
Low secondary transmission of 2009 pandemic influenza A (H1N1) in households following an outbreak at a summer camp: relationship to timing of exposure. Epidemiol Infect. 2010.
PubMed Abstract available
Grantham ML, Stewart SM, Lalime EN, Pekosz A, et al.
Tyrosines in the influenza A virus M2 protein cytoplasmic tail are critical for the production of infectious virus particles. J Virol. 2010.
PubMed Abstract available
Fislova T, Thomas B, Graef KM, Fodor E, et al.
Association of the influenza virus RNA polymerase subunit PB2 with the host chaperonin CCT. J Virol. 2010.
PubMed Abstract available
Uyeki TM.
2009 H1N1 virus transmission and outbreaks. N Engl J Med. 2010;362:2221-3.
PubMed
Cowling BJ, Chan KH, Fang VJ, Lau LL, et al.
Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med. 2010;362:2175-84.
PubMed Abstract available
Lee VJ, Yap J, Cook AR, Chen MI, et al.
Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks. N Engl J Med. 2010;362:2166-74.
PubMed Abstract available
Stittelaar KJ, Lacombe V, van Lavieren R, van Amerongen G, et al.
Cross-clade immunity in cats vaccinated with a canarypox-vectored avian influenza vaccine. Vaccine. 2010.
PubMed Abstract available
Kanai Y, Boonsathorn N, Chittaganpitch M, Bai G, et al.
The impact of antigenic drift of influenza A virus on human herd immunity: Sero-epidemiological study of H1N1 in healthy Thai population in 2009. Vaccine. 2010.
PubMed Abstract available
Singh S, Toro H, Tang DC, Briles WE, et al.
Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8(+) T lymphocytes. Virology. 2010.
PubMed Abstract available
-
------
Research Articles Abstracts - July 2 2010 Issue
Research Articles Abstracts - July 2 2010 Issue
Research Articles Abstracts - July 2 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstracts - July 2 2010 Issue
Palmer SM, Limaye AP, Banks M, Gallup D, et al.
Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial. Ann Intern Med. 2010;152:761-9.
PubMed Abstract available
Pillai SP, Pantin-Jackwood M, Suarez DL, Saif YM, et al.
Pathobiological characterization of low-pathogenicity H5 avian influenza viruses of diverse origins in chickens, ducks and turkeys. Arch Virol. 2010.
PubMed Abstract available
Abraham T.
The price of poor pandemic communication. BMJ. 2010;340:c2952.
PubMed
Bonneux L, Van Damme W.
Preventing iatrogenic pandemics of panic. Do it in a NICE way. BMJ. 2010;340:c3065.
PubMed
Collignon P, Doshi P, Jefferson T.
Child influenza vaccination. Ramifications of adverse events in children in Australia. BMJ. 2010;340:c2994.
PubMed
Le QM, Ito M, Muramoto Y, Hoang PV, et al.
Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans from 2003 to 2008 in Northern Vietnam. J Gen Virol. 2010.
PubMed Abstract available
Skountzou I, Koutsonanos DG, Kim JH, Powers R, et al.
Immunity to Pre-1950 H1N1 Influenza Viruses Confers Cross-Protection against the Pandemic Swine-Origin 2009 A (H1N1) Influenza Virus. J Immunol. 2010.
PubMed Abstract available
Coomes SM, Wilke CA, Moore TA, Moore BB, et al.
Induction of TGF-{beta}1, Not Regulatory T Cells, Impairs Antiviral Immunity in the Lung following Bone Marrow Transplant. J Immunol. 2010.
PubMed Abstract available
Wu B, Wang C, Dong G, Guo Y, et al.
New Evidence Suggests Southern China as a Common Source of Multiple Clusters of Highly Pathogenic H5N1 Avian Influenza Virus. J Infect Dis. 2010.
PubMed Abstract available
Dudek SE, Luig C, Pauli EK, Schubert U, et al.
The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state. J Virol. 2010.
PubMed Abstract available
Crepin T, Dias A, Palencia A, Swale C, et al.
Mutational and metal binding analysis of the endonuclease domain of the influenza virus polymerase PA subunit. J Virol. 2010.
PubMed Abstract available
Ilyushina NA, Khalenkov AM, Seiler JP, Forrest HL, et al.
Adaptation of pandemic H1N1 influenza viruses in mice. J Virol. 2010.
PubMed Abstract available
Teijaro JR, Verhoeven D, Page CA, Turner D, et al.
Memory CD4 T cells Direct Protective Responses to Influenza Virus in the Lung through Helper-independent Mechanisms. J Virol. 2010.
PubMed Abstract available
Kaminski A, Poyry TA, Skene PJ, Jackson RJ, et al.
Mechanism of initiation site selection promoted by the human rhinovirus 2 internal ribosome entry site. J Virol. 2010;84:6578-89.
PubMed Abstract available
Gilman SL.
Moral panic and pandemics. Lancet. 2010;375:1866-7.
PubMed
Hens N, Van Ranst M, Aerts M, Robesyn E, et al.
Estimating the effective reproduction number for pandemic influenza from notification data made publicly available in real time: A multi-country analysis for influenza A/H1N1v 2009. Vaccine. 2010.
PubMed Abstract available
Looijmans-van den Akker I, van Delden JJ, Verheij TJ, van der Sande MA, et al.
Effects of a multi-faceted program to increase influenza vaccine uptake among health care workers in nursing homes: A cluster randomised controlled trial. Vaccine. 2010.
PubMed Abstract available
Fairbrother G, Cassedy A, Ortega-Sanchez IR, Szilagyi PG, et al.
High costs of influenza: Direct medical costs of influenza disease in young children. Vaccine. 2010.
PubMed Abstract available
Chen Y, Zhong G, Wang G, Deng G, et al.
Dogs are highly susceptible to H5N1 avian influenza virus. Virology. 2010.
PubMed Abstract available
Song JM, Hossain J, Yoo DG, Lipatov AS, et al.
Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles. Virology. 2010.
PubMed Abstract available
Nguyen HT, Sheu TG, Mishin VP, Klimov AI, et al.
Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays. Antimicrob Agents Chemother. 2010.
PubMed Abstract available
-
------
Research Articles Abstracts - July 9 2010 Issue
Research Articles Abstracts - July 9 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstracts - July 9 2010 Issue
Hurt AC, Lowther S, Middleton D, Barr IG, et al.
Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.
Antiviral Res. 2010.
PubMed Abstract available
Laurell AC, Herrera JR.
WHO and pandemic flu. What happened in Mexico. BMJ. 2010;340:c3465.
PubMed
Kon P.
WHO and pandemic flu. GlaxoSmithKline UK responds. BMJ. 2010;340:c3464.
PubMed
Chan M.
WHO Director-General replies to the BMJ. BMJ. 2010;340:c3463.
PubMed
Jefferson T, Doshi P.
WHO and pandemic flu. Time for change, WHO. BMJ. 2010;340:c3461.
PubMed
Law R.
WHO and pandemic flu. There was also no new subtype. BMJ. 2010;340:c3460.
PubMed
Doshi P, Jefferson T.
WHO and pandemic flu. Another question for GSK. BMJ. 2010;340:c3455.
PubMed
McLean E, Pebody RG, Campbell C, Chamberland M, et al.
Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases. Epidemiol Infect. 2010.
PubMed Abstract available
Maltezou HC, Dedoukou X, Patrinos S, Maragos A, et al.
Determinants of Intention to get vaccinated against Novel (Pandemic) Influenza A H1N1 among Health-Care Workers in a Nationwide Survey. J Infect. 2010.
PubMed Abstract available
Lalayianni C.
Outbreak of novel influenza a (h1n1) in an adult haematology department and haematopoietic cell transplantation unit: Clinical presentation and outcome. J Infect. 2010.
PubMed
Chowell G, Viboud C, Simonsen L, Miller MA, et al.
Mortality Patterns Associated with the 1918 Influenza Pandemic in Mexico: Evidence for a Spring Herald Wave and Lack of Preexisting Immunity in Older Populations. J Infect Dis. 2010.
PubMed Abstract available
Acosta EP, Jester P, Gal P, Wimmer J, et al.
Oseltamivir Dosing for Influenza Infection in Premature Neonates. J Infect Dis. 2010.
PubMed Abstract available
Esposito DH, Gardner TJ, Schneider E, Stockman LJ, et al.
Outbreak of pneumonia associated with emergent human adenovirus serotype 14--Southeast Alaska, 2008. J Infect Dis. 2010;202:214-22.
PubMed Abstract available
Chidlow GR, Harnett GB, Williams SH, Tempone SS, et al.
The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay. J Virol Methods. 2010.
PubMed Abstract available
Chapman GB, Li M, Colby H, Yoon H, et al.
Opting in vs opting out of influenza vaccination. JAMA. 2010;304:43-4.
PubMed
Song H, Wittman V, Byers A, Tapia T, et al.
In vitro stimulation of human influenza-specific CD8(+) T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine. Vaccine. 2010.
PubMed Abstract available
Torun SD, Torun F.
Vaccination against pandemic influenza A/H1N1 among healthcare workers and reasons for refusing vaccination in Istanbul in last pandemic alert phase. Vaccine. 2010.
PubMed Abstract available
Lin J, Somanathan S, Roy S, Calcedo R, et al.
Lung homing CTLs and their proliferation ability are important correlates of vaccine protection against influenza. Vaccine. 2010.
PubMed Abstract available
Lu CY, Shao PL, Chang LY, Huang YC, et al.
Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents. Vaccine. 2010.
PubMed Abstract available
Oh CE, Lee J, Kang JH, Hong YJ, et al.
Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: A prospective, open-label, multi-center trial. Vaccine. 2010.
PubMed Abstract available
Hara M, Tanaka K, Kase T, Maeda A, et al.
Evaluation of seasonal influenza vaccination effectiveness based on antibody efficacy among the institutionalized elderly in Japan. Vaccine. 2010.
PubMed Abstract available
Carmona A, Omenaca F, Tejedor JC, Merino JM, et al.
Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months. Vaccine. 2010.
PubMed Abstract available
Misplon JA, Lo CY, Gabbard JD, Tompkins SM, et al.
Genetic control of immune responses to influenza A matrix 2 protein (M2). Vaccine. 2010.
PubMed Abstract available
Keawcharoen J, Spronken MI, Vuong O, Bestebroer TM, et al.
Repository of Eurasian influenza A virus hemagglutinin and neuraminidase reverse genetics vectors and recombinant viruses. Vaccine. 2010.
PubMed Abstract available
Kraigher A, Ucakar V.
Surveillance of adverse events following immunization against pandemic influenza in Slovenia in season 2009/10. Vaccine. 2010.
PubMed Abstract available
Bozzola E, Krzysztofiak A, Lancella L, Tozzi A, et al.
Risk factors of complicated H1N1 influenza in hospitalized Italian children. Vaccine. 2010.
PubMed Abstract available
Riffault S, Meyer G, Deplanche M, Dubuquoy C, et al.
A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus. Vaccine. 2010.
PubMed Abstract available
Furuse Y, Shimabukuro K, Odagiri T, Sawayama R, et al.
Comparison of selection pressures on the HA gene of pandemic (2009) and seasonal human and swine influenza A H1 subtype viruses. Virology. 2010.
PubMed Abstract available
-
-----
Research Articles Abstracts - July 16 2010 Issue
Research Articles Abstracts - July 16 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstracts - July 16 2010 Issue
Saha RK, Takahashi T, Kurebayashi Y, Fukushima K, et al.
Antiviral effect of strictinin on influenza virus replication. Antiviral Res. 2010.
PubMed Abstract available
Zarocostas J.
WHO swine flu review committee promises to probe links with drug industry. BMJ. 2010;341:c3648.
PubMed
Du L, Zhao G, Zhang X, Liu Z, et al.
Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies. Biochem Biophys Res Commun. 2010;397:580-5.
PubMed Abstract available
Boltz DA, Aldridge JR Jr, Webster RG, Govorkova EA, et al.
Drugs in development for influenza. Drugs. 2010;70:1349-62.
PubMed Abstract available
Song MS, Lee JH, Pascua PN, Baek YH, et al.
Evidence of human-to-swine transmission of the pandemic (H1N1) 2009 influenza virus in South Korea. J Clin Microbiol. 2010.
PubMed Abstract available
Wenzel JJ, Panning M, Kaul KL, Mangold KA, et al.
Analytical Performance Determination and Clinical Validation of the Novel Roche RealTime ready Influenza A/H1N1 Detection Set. J Clin Microbiol. 2010.
PubMed Abstract available
Jiang WM, Liu S, Chen J, Hou GY, et al.
Molecular epidemiological surveys of H5 subtype highly pathogenic avian influenza viruses in poultry in China in 2007-2009. J Gen Virol. 2010.
PubMed Abstract available
Widjaja I, de Vries E, Tscherne DM, Garcia-Sastre A, et al.
Inhibition of the ubiquitin-proteasome system affects influenza A virus infection at a post-fusion step. J Virol. 2010.
PubMed Abstract available
Hurt AC, Nor'e SS, McCaw JM, Fryer HR, et al.
Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets using a competitive mixtures model. J Virol. 2010.
PubMed Abstract available
Moncorge O, Mura M, Barclay WS.
Evidence for avian and human host cell factors that affect the activity of influenza polymerase. J Virol. 2010.
PubMed Abstract available
Bertram S, Glowacka I, Blazejewska P, Soilleux E, et al.
TMPRSS2 and TMPRSS4 facilitate trypsin-independent influenza virus spread in Caco-2 cells. J Virol. 2010.
PubMed Abstract available
Negovetich NJ, Webster RG.
Thermostability of subpopulations of H2N3 influenza isolates from Mallard ducks. J Virol. 2010.
PubMed Abstract available
Gras S, Kedzierski L, Valkenburg SA, Laurie K, et al.
Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc Natl Acad Sci U S A. 2010;107:12599-604.
PubMed Abstract available
Bommakanti G, Citron MP, Hepler RW, Callahan C, et al.
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge. Proc Natl Acad Sci U S A. 2010.
PubMed Abstract available
Grandea AG 3rd, Olsen OA, Cox TC, Renshaw M, et al.
Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses. Proc Natl Acad Sci U S A. 2010;107:12658-63.
PubMed Abstract available
Gravel C, Li C, Wang J, Hashem AM, et al.
Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences. Vaccine. 2010.
PubMed Abstract available
Lee BY, Bailey RR, Wiringa AE, Afriyie A, et al.
Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza. Vaccine. 2010.
PubMed Abstract available
Venkat A, Chan-Tompkins NH, Hegde GG, Chuirazzi DM, et al.
Feasibility of integrating a clinical decision support tool into an existing computerized physician order entry system to increase seasonal influenza vaccination in the emergency department. Vaccine. 2010.
PubMed Abstract available
Moules V, Ferraris O, Terrier O, Giudice E, et al.
In vitro characterization of naturally occurring influenza H3NA- viruses lacking the NA gene segment: Toward a new mechanism of viral resistance? Virology. 2010.
PubMed Abstract available
Watanabe R, Lamb RA.
Influenza virus budding does not require a functional AAA+ ATPase, VPS4. Virus Res. 2010.
PubMed Abstract available
-
------
Research Articles Abstracts - July 22 2010 Issue
Research Articles Abstracts - July 22 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstracts - July 22 2010 Issue
Sundararajan A, Ganapathy R, Huan L, Dunlap JR, et al.
Influenza virus variation in susceptibility to inactivation by pomegranate polyphenols is determined by envelope glycoproteins. Antiviral Res. 2010.
PubMed Abstract available
Smee DF, Hurst BL, Wong MH, Tarbet EB, et al.
Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice. Antiviral Res. 2010.
PubMed Abstract available
Mueller SN, Langley WA, Li G, Garcia-Sastre A, et al.
Qualitatively Different Memory CD8+ T Cells Are Generated after Lymphocytic Choriomeningitis Virus and Influenza Virus Infections. J Immunol. 2010.
PubMed Abstract available
Limper M, Smit PM, Bongers KM, van Zanten AP, et al.
Procalcitonin in children with suspected Novel Influenza A (H1N1) infection. J Infect. 2010.
PubMed
Wu J, Li W, Wang HQ, Chen JT, et al.
A Rapid Immune Response to 2009 Influenza A(H1N1) Vaccines in Adults: A Randomized, Double-Blind, Controlled Trial. J Infect Dis. 2010.
PubMed Abstract available
Wu J, Liu SZ, Dong SS, Dong XP, et al.
Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: A phase I-II randomized trial. Vaccine. 2010.
PubMed Abstract available
Lin CJ, Nowalk MP, Toback SL, Rousculp MD, et al.
Importance of vaccination habit and vaccine choice on influenza vaccination among healthy working adults. Vaccine. 2010.
PubMed Abstract available
Petersson P, Hedenskog M, Alves D, Brytting M, et al.
The Eurocine((R)) L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination. Vaccine. 2010.
PubMed Abstract available
Dedoukou X, Nikolopoulos G, Maragos A, Giannoulidou S, et al.
Attitudes towards vaccination against seasonal influenza of health-care workers in primary health-care settings in Greece. Vaccine. 2010.
PubMed Abstract available
Reemers SS, Jansen C, Koerkamp MJ, van Haarlem D, et al.
Reduced immune reaction prevents immunopathology after challenge with avian influenza virus: A transcriptomics analysis of adjuvanted vaccines. Vaccine. 2010.
PubMed Abstract available
-
------
Research Articles Abstracts - July 31 2010 Issue
Research Articles Abstracts - July 31 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstracts - July 31 2010 Issue
...
Influenza vaccination of children and adolescents decreased influenza infection in nonvaccinated community members. Ann Intern Med. 2010;153:JC110.
PubMed
Casalegno JS, Bouscambert-Duchamp M, Caro V, Schuffenecker I, et al.
Oseltamivir-resistant influenza A(H1N1) viruses in south of France, 2007/2009. Antiviral Res. 2010;87:242-8.
PubMed Abstract available
Yoo JK, Baker DP, Fish EN.
Interferon-beta modulates type 1 immunity during influenza virus infection. Antiviral Res. 2010.
PubMed Abstract available
Guo L, Zheng M, Ding Y, Li D, et al.
Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein. Arch Virol. 2010.
PubMed Abstract available
Operario DJ, Moser MJ, St George K.
Highly Sensitive and Quantitative Detection of the H274Y Oseltamivir Resistance Mutation in Seasonal A/H1N1 Influenza. J Clin Microbiol. 2010.
PubMed Abstract available
Lines JL, Hoskins S, Hollifield M, Cauley LS, et al.
The Migration of T Cells in Response to Influenza Virus Is Altered in Neonatal Mice. J Immunol. 2010.
PubMed Abstract available
Tsatsanis C, Margioris AN, Kontoyiannis DP.
Association between H1N1 infection severity and obesity-adiponectin as a potential etiologic factor. J Infect Dis. 2010;202:459-60.
PubMed
Bulach D, Halpin R, Spiro D, Pomeroy L, et al.
Molecular analysis of H7 avian influenza viruses from Australia and New Zealand: Genetic diversity and relationships - 1976 to 2007. J Virol. 2010.
PubMed Abstract available
Chen CJ, Chen GW, Wang CH, Huang CH, et al.
Differential localization and function of PB1-F2 derived from different strains of influenza A virus. J Virol. 2010.
PubMed Abstract available
Stoner TD, Krauss S, Dubois RM, Negovetich NJ, et al.
Antiviral Susceptibility of Avian and Swine Influenza of the N1 Neuraminidase Subtype. J Virol. 2010.
PubMed Abstract available
Trento A, Casas I, Calderon A, Garcia-Garcia ML, et al.
Ten years of global evolution of the human respiratory syncytial virus BA genotype with a 60-nucleotide duplication in the G protein gene. J Virol. 2010;84:7500-12.
PubMed Abstract available
Gern JE.
The ABCs of rhinoviruses, wheezing, and asthma. J Virol. 2010;84:7418-26.
PubMed Abstract available
Cheung TK, Chin AW, Chan KH, Schumaker M, et al.
Evaluation of novel H1N1-specific primer-probe sets using commercial RT-PCR mixtures and a premixed reaction stored in a lyophilized format. J Virol Methods. 2010;165:302-4.
PubMed Abstract available
Eckert DM, Kay MS.
Stalking influenza. Proc Natl Acad Sci U S A. 2010.
PubMed
Rosenberg MR, Casarotto MG.
Coexistence of two adamantane binding sites in the influenza A M2 ion channel. Proc Natl Acad Sci U S A. 2010.
PubMed Abstract available
Girard MP, Katz J, Pervikov Y, Palkonyay L, et al.
Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010. Vaccine. 2010.
PubMed Abstract available
Jimenez-Garcia R, Hernandez-Barrera V, de Andres AL, Jimenez-Trujillo I, et al.
Gender influence in influenza vaccine uptake in Spain: Time trends analysis (1995-2006). Vaccine. 2010.
PubMed Abstract available
Kao TM, Hsieh SM, Kung HC, Lee YC, et al.
Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly. Vaccine. 2010.
PubMed Abstract available
Opstelten W, van Essen GA, Heijnen ML, Ballieux MJ, et al.
High vaccination rates for seasonal and pandemic (A/H1N1) influenza among healthcare workers in Dutch general practice. Vaccine. 2010.
PubMed Abstract available
Langley WA, Li ZN, Bradley KC, Talekar GR, et al.
The effects of preexisting immunity to influenza on responses to influenza vectors in mice. Vaccine. 2010.
PubMed Abstract available
Foty RG, Guttmann A, Kwong JC, Maaten S, et al.
Predictors of universal influenza vaccination uptake in grades 1 and 2 Toronto school children: Effective vaccination strategies should not end with at risk children. Vaccine. 2010.
PubMed Abstract available
Lapphra K, Dobson S, Bettinger J.
Acceptability of Internet adverse event self-reporting for pandemic and seasonal influenza immunization among health care workers. Vaccine. 2010.
PubMed Abstract available
Rodriguez-Rieiro C, Dominguez-Berjon MF, Esteban-Vasallo MD, Sanchez-Perruca L, et al.
Vaccination coverage against 2009 seasonal influenza in chronically ill children and adults: Analysis of population registries in primary care in Madrid (Spain). Vaccine. 2010.
PubMed Abstract available
Shahid Z, Kleppinger A, Gentleman B, Falsey AR, et al.
Clinical and immunologic predictors of influenza illness among vaccinated older adults. Vaccine. 2010.
PubMed Abstract available
Kim S, Jang JE, Yu JR, Chang J, et al.
Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection. Vaccine. 2010.
PubMed Abstract available
Lau YF, Tang LH, Ooi EE, Subbarao K, et al.
Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice. Virology. 2010.
PubMed Abstract available
Cheng X, Xu Q, Song E, Yang CF, et al.
The hemagglutinin protein of influenza A/Vietnam/1203/2004 (H5N1) contributes to hyperinduction of proinflammatory cytokines in human epithelial cells. Virology. 2010.
PubMed Abstract available
Schaap-Nutt A, D'Angelo C, Amaro-Carambot E, Nolan SM, et al.
Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primates. Virology. 2010.
PubMed Abstract available
Stewart SM, Wu WH, Lalime EN, Pekosz A, et al.
The cholesterol recognition/interaction amino acid consensus motif of the influenza A virus M2 protein is not required for virus replication but contributes to virulence. Virology. 2010.
PubMed Abstract available
Panozzo CA, Stockman LJ, Curns AT, Anderson LJ, et al.
Use of respiratory syncytial virus surveillance data to optimize the timing of immunoprophylaxis. Pediatrics. 2010;126:e116-23.
PubMed Abstract available
-
------
Research Articles Abstracts - August 8 2010 Issue
Research Articles Abstracts - August 8 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstracts - August 8 2010 Issue
Casalegno JS, Bouscambert-Duchamp M, Caro V, Schuffenecker I, et al.
Oseltamivir-resistant influenza A(H1N1) viruses in south of France, 2007/2009. Antiviral Res. 2010.
PubMed Abstract available
Du L, Zhao G, Zhang X, Liu Z, et al.
Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies. Biochem Biophys Res Commun. 2010.
PubMed Abstract available
Dhiman N, Espy MJ, Irish CL, Wright PA, et al.
Evidence for Amino Acid Changes in a 57 base-pair Region of Highly Conserved Matrix Gene of Pandemic (H1N1) 2009 Influenza A Virus. J Clin Microbiol. 2010.
PubMed Abstract available
Guervilly C, Coisel Y, Botelho-Nevers E, Dizier S, et al.
Significance of high levels of Procalcitonin in patients with Influenza A (H1N1) pneumonia. J Infect. 2010.
PubMed
Komiya N, Gu Y, Kamiya H, Yahata Y, et al.
Household transmission of pandemic 2009 influenza A (H1N1) virus in Osaka, Japan in May 2009. J Infect. 2010.
PubMed Abstract available
Yang P, Deng Y, Pang X, Shi W, et al.
Severe, critical and fatal cases of 2009 H1N1 influenza in China. J Infect. 2010.
PubMed Abstract available
Cowling BJ, Ng DM, Ip DK, Liao Q, et al.
Community Psychological and Behavioral Responses through the First Wave of the 2009 Influenza A(H1N1) Pandemic in Hong Kong. J Infect Dis. 2010.
PubMed Abstract available
Dao CN, Kamimoto L, Nowell M, Reingold A, et al.
Adult Hospitalizations for Laboratory-Positive Influenza during the 2005-2006 through 2007-2008 Seasons in the United States. J Infect Dis. 2010.
PubMed Abstract available
Zielecki F, Semmler I, Kalthoff D, Voss D, et al.
Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: The role of the C-terminal ESEV motif in the viral NS1 protein. J Virol. 2010.
PubMed Abstract available
Octaviani CP, Ozawa M, Yamada S, Goto H, et al.
High genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J Virol. 2010.
PubMed Abstract available
Bosch BJ, Bodewes R, de Vries RP, Kreijtz JH, et al.
Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets. J Virol. 2010.
PubMed Abstract available
Jahangir A, Ruenphet S, Hara K, Shoham D, et al.
Evaluation of human intestinal epithelial differentiated cells (Caco-2) for replication, plaque formation and isolation of avian influenza viruses. J Virol Methods. 2010.
PubMed Abstract available
Mu B, Huang X, Bu P, Zhuang J, et al.
Influenza virus detection with pentabody-activated nanoparticles. J Virol Methods. 2010.
PubMed Abstract available
Dhumpa R, Bu M, Handberg KJ, Wolff A, et al.
Rapid sample preparation for detection and identification of avian influenza virus from chicken faecal samples using magnetic bead microsystem. J Virol Methods. 2010.
PubMed Abstract available
...
Regional Influenza A (H1N1) 2009 Monovalent Vaccination Campaign --- Skokie, Illinois, October 16--December 31, 2009. MMWR Morb Mortal Wkly Rep. 2010;59:909-13.
PubMed Abstract available
...
Update: influenza activity --- United States, 2009--10 season. MMWR Morb Mortal Wkly Rep. 2010;59:901-8.
PubMed Abstract available
Pearton M, Kang SM, Song JM, Kim YC, et al.
Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. Vaccine. 2010.
PubMed Abstract available
Sealy R, Jones BG, Surman SL, Hurwitz JL, et al.
Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1. Vaccine. 2010.
PubMed Abstract available
Zimmerman RK, Lauderdale DS, Tan SM, Wagener DK, et al.
Prevalence of high-risk indications for influenza vaccine varies by age, race, and income. Vaccine. 2010.
PubMed Abstract available
Esposito S, Marchisio P, Ansaldi F, Bianchini S, et al.
A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6-35 months. Vaccine. 2010.
PubMed Abstract available
Robach JG, Lamb RA.
Analysis of parainfluenza virus-5 hemagglutinin-neuraminidase protein mutants that are blocked in internalization and degradation. Virology. 2010.
PubMed Abstract available
Sakoda Y, Sugar S, Batchluun D, Erdene-Ochir TO, et al.
Characterization of H5N1 highly pathogenic avian influenza virus strains isolated from migratory waterfowl in Mongolia on the way back from the southern Asia to their northern territory. Virology. 2010.
PubMed Abstract available
-
------
Research Articles Abstracts - August 14 2010 Issue
Research Articles Abstracts - August 14 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstracts - August 14 2010 Issue
Grund S, Roggendorf M, Schweiger B.
Outbreak of influenza virus A/H1N1 in a hospital ward for immunocompromised patients. Arch Virol. 2010.
PubMed Abstract available
Lopert R, Nolan T.
Child influenza vaccination. Panvax febrile reactions not a predictor. BMJ. 2010;341:c3714.
PubMed
Curran MP, Leroux-Roels I.
Inactivated split-virion seasonal influenza vaccine (fluarix(r)): a review of its use in the prevention of seasonal influenza in adults and the elderly. Drugs. 2010;70:1519-43.
PubMed Abstract available
Sintes X, Nebot M, Izquierdo C, Ruiz L, et al.
Factors associated with pneumococcal and influenza vaccination in hospitalized people aged 65 years. Epidemiol Infect. 2010.
PubMed Abstract available
Ortiz de la Tabla V, Masia M, Antequera P, Martin C, et al.
Comparison of Combined Nose-Throat Swabs with Nasopharyngeal Aspirates for Detection of Pandemic Influenza A/H1N1 2009 Virus by Real-time RT-PCR. J Clin Microbiol. 2010.
PubMed Abstract available
O'Leary MF, Chappell JD, Stratton CW, Cronin RM, et al.
Complex Febrile Seizures Followed by Complete Recovery in an Infant with High Titer 2009 Pandemic Influenza A (H1N1) Infection. J Clin Microbiol. 2010.
PubMed Abstract available
van Leeuwen M, Williams MM, Koraka P, Simon JH, et al.
Human picobirnaviruses identified by molecular screening of diarrhea samples. J Clin Microbiol. 2010;48:1787-94.
PubMed Abstract available
Lebouder F, Lina B, Rimmelzwaan GF, Riteau B, et al.
Plasminogen promotes Influenza A virus replication through an annexin II-dependent pathway in absence of neuraminidase. J Gen Virol. 2010.
PubMed Abstract available
Resa-Infante P, Recuero-Checa MA, Zamarreno N, Llorca O, et al.
Structural and functional characterisation of an influenza virus RNA polymerase-genomic RNA complex. J Virol. 2010.
PubMed Abstract available
Coombs KM, Berard A, Xu W, Krokhin O, et al.
Quantitative Proteomic Analyses of Influenza virus-Infected Cultured Human Lung Cells. J Virol. 2010.
PubMed Abstract available
Ping J, Dankar SK, Forbes NE, Keleta L, et al.
PB2 and HA Mutations are Major Determinants of Host Range and Virulence in Mouse-Adapted Influenza A Virus. J Virol. 2010.
PubMed Abstract available
Liu H, Golebiewski L, Dow EC, Krug RM, et al.
The ESEV PDZ Binding-Motif of the Avian Influenza A Virus NS1 Protein Protects Infected Cells from Apoptosis through Directly Targeting Scribble. J Virol. 2010.
PubMed Abstract available
Barry MA.
A 29-year-old woman with flu-like symptoms: review of influenza diagnosis and treatment. JAMA. 2010;304:671-8.
PubMed Abstract available
Mitka M.
H1N1 influenza virus reassorting in pigs, poses unknown risk to human health. JAMA. 2010;304:626-7.
PubMed
...
Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Regarding Use of CSL Seasonal Influenza Vaccine (Afluria) in the United States During 2010--11. MMWR Morb Mortal Wkly Rep. 2010;59:989-92.
PubMed Abstract available
Acharya R, Carnevale V, Fiorin G, Levine BG, et al.
Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus. Proc Natl Acad Sci U S A. 2010.
PubMed Abstract available
Heynisch B, Frensing T, Heinze K, Seitz C, et al.
Differential activation of host cell signalling pathways through infection with two variants of influenza A/PR/8/34 (H1N1) in MDCK cells. Vaccine. 2010.
PubMed Abstract available
Ameiss K, Ashraf S, Kong W, Pekosz A, et al.
Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype. Vaccine. 2010.
PubMed Abstract available
Feng L, Mounts AW, Feng Y, Luo Y, et al.
Seasonal influenza vaccine supply and target vaccinated population in China, 2004-2009. Vaccine. 2010.
PubMed Abstract available
Thueng-In K, Maneewatch S, Srimanote P, Songserm T, et al.
Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines. Vaccine. 2010.
PubMed Abstract available
-
-----
Research Articles Abstracts - August 20 2010 Issue
Research Articles Abstracts - August 20 2010 Issue
[Source: US National Library of Medicine (
LINK ). Edited.]
Research Articles Abstracts - August 20 2010 Issue
Sweet M.
Australian health authorities' response criticised after adverse events related to influenza vaccination in children. BMJ. 2010;341:c4470.
PubMed
Girard M.
Competing interests. More queries about H1N1 scandal. BMJ. 2010;341:c3716.
PubMed
Stevenson HL, Loeffelholz MJ.
Poor Positive Accuracy of Quickvue Rapid Antigen Tests During the Influenza A (H1N1) 2009 Pandemic. J Clin Microbiol. 2010.
PubMed Abstract available
Kreijtz JH, Suezer Y, Bodewes R, Schwantes A, et al.
Evaluation of an MVA-based candidate pandemic influenza A/H1N1 vaccine in the ferret model. J Gen Virol. 2010.
PubMed Abstract available
Ong MP, Sam IC, Azwa H, Mohd Zakaria IE, et al.
Direct healthcare costs of patients hospitalised with pandemic (h1n1) 2009 influenza in malaysia. J Infect. 2010.
PubMed
Isais F, Chow A, Lye DC, Llorin R, et al.
Pandemic (h1n1) 2009 influenza in hiv-infected adults: clinical features, severity, and outcome. J Infect. 2010.
PubMed
Laurie KL, Carolan LA, Middleton D, Lowther S, et al.
Multiple Infections with Seasonal Influenza A Virus Induce Cross-Protective Immunity against A(H1N1) Pandemic Influenza Virus in a Ferret Model. J Infect Dis. 2010.
PubMed Abstract available
Chao DL, Elizabeth Halloran M, Longini IM Jr.
School Opening Dates Predict Pandemic Influenza A(H1N1) Outbreaks in the United States. J Infect Dis. 2010;202:877-80.
PubMed Abstract available
Khatri M, Dwivedi V, Krakowka S, Manickam C, et al.
Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus. J Virol. 2010.
PubMed Abstract available
Wan Y, Zhou Z, Yang Y, Wang J, et al.
Application of an In-Cell Western assay for measurement of influenza A virus replication. J Virol Methods. 2010.
PubMed Abstract available
Leiding T, Wang J, Martinsson J, Degrado WF, et al.
Proton and cation transport activity of the M2 proton channel from influenza A virus. Proc Natl Acad Sci U S A. 2010.
PubMed Abstract available
Morelon E, Noble CP, Daoud S, Cahen R, et al.
Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination. Vaccine. 2010.
PubMed Abstract available
Masic A, Lu X, Li J, Mutwiri GK, et al.
Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs. Vaccine. 2010.
PubMed Abstract available
Poland GA.
Mandating influenza vaccination for health care workers: Putting patients and professional ethics over personal preference. Vaccine. 2010;28:5757-9.
PubMed
Ramey AM, Pearce JM, Ely CR, Sheffield Guy LM, et al.
Transmission and reassortment of avian influenza viruses at the Asian-North American interface. Virology. 2010.
PubMed Abstract available
Kanai Y, Chittaganpitch M, Nakamura I, Li GM, et al.
Distinct propagation efficiencies of H5N1 influenza virus Thai isolates in newly established murine respiratory region-derived cell clones. Virus Res. 2010.
PubMed Abstract available
Kohno S, Kida H, Mizuguchi M, Shimada J, et al.
Efficacy and safety of intravenous peramivir for the treatment of seasonal influenza. Antimicrob Agents Chemother. 2010.
PubMed Abstract available
-
------
Research Articles Abstracts - August 28 2010 Issue
Research Articles Abstracts - August 28 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstracts - August 28 2010 Issue
Dharan NJ, Beekmann SE, Fiore A, Finelli L, et al.
Influenza Antiviral Prescribing Practices during the 2007-08 and 2008-09 Influenza Seasons in the Setting of Increased Resistance to Oseltamivir among Circulating Influenza Viruses. Antiviral Res. 2010.
PubMed Abstract available
Kmietowicz Z.
WHO declares that H1N1 pandemic is officially over. BMJ. 2010;341:c4393.
PubMed
Renois F, Talmud D, Huguenin A, Moutte L, et al.
Rapid Detection of Respiratory Tract Viral infections and Co-infections in Patients with Influenza-like Illnesses by Use of RT-PCR DNA Microarray Systems. J Clin Microbiol. 2010.
PubMed Abstract available
Wang S, Le TQ, Kurihara N, Chida J, et al.
Influenza Virus-Cytokine-Protease Cycle in the Pathogenesis of Vascular Hyperpermeability in Severe Influenza. J Infect Dis. 2010.
PubMed Abstract available
Marcus PI, Ngunjiri JM, Sekellick MJ, Wang L, et al.
In Vitro Analysis of Virus Particle Subpopulations in Candidate Live-Attenuated Influenza Vaccines Distinguishes Effective from Ineffective Vaccines. J Virol. 2010.
PubMed Abstract available
Seibert CW, Kaminski M, Philipp J, Rubbenstroth D, et al.
Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. J Virol. 2010.
PubMed Abstract available
Jewell NA, Cline T, Mertz SE, Smirnov SV, et al.
Interferon-{lambda} is the predominant interferon induced by influenza A virus infection in vivo. J Virol. 2010.
PubMed Abstract available
...
Pandemic influenza--(some) reasons to be cheerful? Lancet. 2010;376:565.
PubMed
Bryan P, Seabroke S, Davies C.
H1N1 vaccine safety: real-time surveillance in the UK. Lancet. 2010;376:417-8.
PubMed
Zhao G, Du L, Xiao W, Sun S, et al.
Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant. Vaccine. 2010.
PubMed Abstract available
Carlson SJ, Durrheim DN, Dalton CB.
Flutracking provides a measure of field influenza vaccine effectiveness, Australia, 2007-2009. Vaccine. 2010.
PubMed Abstract available
Heldens JG, Pouwels HG, Derks CG, Van de Zande SM, et al.
Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix. Vaccine. 2010.
PubMed Abstract available
Rudolf M, Poppel M, Frohlich A, Breithaupt A, et al.
Longitudinal 2 years field study of conventional vaccination against highly pathogenic avian influenza H5N1 in layer hens. Vaccine. 2010.
PubMed Abstract available
Tang XC, Lu HR, Ross TM.
Hemagglutinin Displayed Baculovirus Protects Against Highly Pathogenic Influenza. Vaccine. 2010.
PubMed Abstract available
Kawakami K, Ohkusa Y, Kuroki R, Tanaka T, et al.
Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan. Vaccine. 2010.
PubMed Abstract available
Lee VJ, Tay JK, Chen MI, Phoon MC, et al.
Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains. Vaccine. 2010.
PubMed Abstract available
-
------
Research Articles Abstracts - September 3 2010 Issue
Research Articles Abstracts - September 3 2010 Issue
Research Articles Abstracts - September 3 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstracts - September 3 2010 Issue
Rowe T, Banner D, Farooqui A, Ng DC, et al.
In vivo ribavirin activity against severe pandemic H1N1 influenza A/Mexico/4108/2009. J Gen Virol. 2010.
PubMed Abstract available
Snyder KM.
Does hand hygiene reduce influenza transmission? J Infect Dis. 2010;202:1146-7.
PubMed
Agrati C, Gioia C, Lalle E, Cimini E, et al.
Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course. J Infect Dis. 2010;202:681-9.
PubMed Abstract available
...
Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep. 2010;59:1057-62.
PubMed Abstract available
Zhang J, While AE, Norman IJ.
Knowledge and attitudes regarding influenza vaccination among nurses: A research review. Vaccine. 2010.
PubMed Abstract available
Andrews N, Stowe J, Wise L, Miller E, et al.
Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom. Vaccine. 2010.
PubMed Abstract available
Chu C, Lugovtsev V, Lewis A, Betenbaugh M, et al.
Production and antigenic properties of influenza virus from suspension MDCK-siat7e cells in a bench-scale bioreactor. Vaccine. 2010.
PubMed Abstract available
Belshe RB.
The need for quadrivalent vaccine against seasonal influenza. Vaccine. 2010;28 Suppl 4
PubMed Abstract available
Monto AS.
Seasonal influenza and vaccination coverage. Vaccine. 2010;28 Suppl 4
PubMed Abstract available
Poland GA.
The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns. Vaccine. 2010;28 Suppl 4
PubMed Abstract available
Falsey AR.
New emerging technologies and the intradermal route: the novel way to immunize against influenza. Vaccine. 2010;28 Suppl 4
PubMed Abstract available
Monto AS.
Seasonal influenza vaccinations: specialized products for different target groups. Vaccine. 2010;28 Suppl 4
PubMed Abstract available
Poland GA.
Putting the puzzle pieces together: the dynamic landscape of influenza vaccine and policy. Vaccine. 2010;28 Suppl 4
PubMed
...
Policy Statement--Recommendations for Prevention and Control of Influenza in Children, 2010-2011. Pediatrics. 2010.
PubMed Abstract available
-
------
Research Articles Abstracts - September 10 2010 Issue
Research Articles Abstracts - September 10 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstracts - September 10 2010 Issue
Kim Y, Narayanan S, Chang KO.
Inhibition of influenza virus replication by plant-derived isoquercetin. Antiviral Res. 2010.
PubMed Abstract available
Yavarian J, Azad TM, Zheng X, Gregory V, et al.
Amantadine resistance in relation to the evolution of influenza A(H3N2) viruses in Iran. Antiviral Res. 2010.
PubMed Abstract available
Thitithanyanont A, Engering A, Uiprasertkul M, Ekchariyawat P, et al.
Antiviral immune responses in H5N1-infected human lung tissue and possible mechanisms underlying the hyperproduction of interferon-inducible protein IP-10. Biochem Biophys Res Commun. 2010;398:752-8.
PubMed Abstract available
Jannetto PJ, Buchan BW, Vaughan KA, Ledford JS, et al.
Real-Time Detection of Influenza A, Influenza B and Respiratory Syncytial Virus A/B in Respiratory Specimens using Nanoparticle Probes. J Clin Microbiol. 2010.
PubMed Abstract available
Han H, Cui ZQ, Wang W, Zhang ZP, et al.
New regulatory mechanisms for the intracellular localization and trafficking of influenza A virus NS1 protein revealed by comparative analysis of A/PR/8/34 and A/Sydney/5/97. J Gen Virol. 2010.
PubMed Abstract available
Job ER, Deng YM, Tate MD, Bottazzi B, et al.
Pandemic H1N1 Influenza A Viruses Are Resistant to the Antiviral Activities of Innate Immune Proteins of the Collectin and Pentraxin Superfamilies. J Immunol. 2010.
PubMed Abstract available
Adler H.
Comment on "Induction of TGF-{beta}1, Not Regulatory T Cells, Impairs Antiviral Immunity in the Lung following Bone Marrow Transplant". J Immunol. 2010;185:1350-1.
PubMed
Lovato-Salas F, Matienzo-Serment L, Monjaras-Avila C, Godoy-Lozano EE, et al.
Pandemic influenza A(H1N1) 2009 and respiratory syncytial virus associated hospitalizations. J Infect. 2010.
PubMed Abstract available
McCullers JA, McAuley JL, Browall S, Iverson AR, et al.
Influenza Enhances Susceptibility to Natural Acquisition of and Disease Due to Streptococcus pneumoniae in Ferrets. J Infect Dis. 2010.
PubMed Abstract available
Li F, Feng L, Pan W, Dong Z, et al.
Generation of replication-competent recombinant influenza A viruses carrying a reporter gene harbored in neuraminidase segment. J Virol. 2010.
PubMed Abstract available
Sorrell EM, Song H, Pena L, Perez DR, et al.
A 27-Amino Acid Deletion in the NA Stalk Supports Respiratory Replication of an Avian H2N2 Influenza A virus in Chickens. J Virol. 2010.
PubMed Abstract available
Liu Y, Childs RA, Matrosovich T, Wharton S, et al.
Altered receptor specificity and cell tropism of D222G haemagglutinin mutants from fatal cases of pandemic A(H1N1) 2009 influenza. J Virol. 2010.
PubMed Abstract available
Belongia EA, Irving SA, Waring SC, Coleman LA, et al.
Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. JAMA. 2010;304:1091-8.
PubMed Abstract available
Suzuki M, Yoshida LM, Ariyoshi K.
Severe pneumonia among Kenyan infants and children. JAMA. 2010;304:964.
PubMed
Nascimento-Carvalho CM, Ruuskanen O.
Severe pneumonia among Kenyan infants and children. JAMA. 2010;304:963.
PubMed
Kung HC, Huang KC, Kao TM, Lee YC, et al.
A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza. Vaccine. 2010.
PubMed Abstract available
Barriere J, Vanjak D, Kriegel I, Otto J, et al.
Acceptance of the 2009 A(H1N1) influenza vaccine among hospital workers in two French cancer centers. Vaccine. 2010.
PubMed Abstract available
Black S, Della Cioppa G, Malfroot A, Nacci P, et al.
Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis. Vaccine. 2010.
PubMed Abstract available
Kitano M, Itoh Y, Kodama M, Ishigaki H, et al.
Establishment of a cynomolgus macaque model of influenza B virus infection. Virology. 2010.
PubMed Abstract available
Poehling KA, Fairbrother G, Zhu Y, Donauer S, et al.
Practice and Child Characteristics Associated With Influenza Vaccine Uptake in Young Children. Pediatrics. 2010.
PubMed Abstract available
Vesikari T, Karvonen A, Tilman S, Borkowski A, et al.
Immunogenicity and Safety of MF59-Adjuvanted H5N1 Influenza Vaccine from Infancy to Adolescence. Pediatrics. 2010.
PubMed Abstract available
-
------
Research Articles Abstracts - September 17 2010 Issue
Research Articles Abstracts - September 17 2010 Issue
[Source: US National Library of Medicine, (
LINK ). Edited.]
Research Articles Abstracts - September 17 2010 Issue
Schoindre Y, Bollee G, Dumont MD, Lesavre P, et al.
Cold Agglutinin Syndrome Associated with a 2009 Influenza A H1N1 Infection. Am J Med. 2010.
PubMed
Minor DS, Eubanks JT, Butler KR Jr, Wofford MR, et al.
Improving Influenza Vaccination Rates by Targeting Individuals not Seeking Early Seasonal Vaccination. Am J Med. 2010.
PubMed Abstract available
Pielak RM, Chou JJ.
Solution NMR structure of the V27A drug resistant mutant of influenza A M2 channel. Biochem Biophys Res Commun. 2010.
PubMed Abstract available
Selvaraju SB, Selvarangan R.
Evaluation of Three Influenza A/B Real-time RT-PCR Assays and a New 2009 H1N1 Assay for Detection of Influenza viruses. J Clin Microbiol. 2010.
PubMed Abstract available
Mehta T, McGrath E, Bheemreddy S, Salimnia H, et al.
Detection of Oseltamivir Resistance During Therapy of 2009 H1N1 Influenza in Immunocompromised Patients: Utility of Cycle Threshold Values of Qualitative rRT-PCR. J Clin Microbiol. 2010.
PubMed Abstract available
Yoo SJ, Moon SJ, Kuak EY, Yoo HM, et al.
Frequent detection of pandemic (H1N1) 2009 virus in stools of hospitalized patients. J Clin Microbiol. 2010;48:2314-5.
PubMed
Le Goffic R, Bouguyon E, Chevalier C, Vidic J, et al.
Influenza A Virus Protein PB1-F2 Exacerbates IFN-{beta} Expression of Human Respiratory Epithelial Cells. J Immunol. 2010.
PubMed Abstract available
Couch RB, Davis BR.
Has Oseltamivir Been Shown to Be Effective for Treatment of H5N1 Influenza? J Infect Dis. 2010.
PubMed
Adisasmito W, Chan PK, Lee N, Oner AF, et al.
Effectiveness of Antiviral Treatment in Human Influenza A(H5N1) Infections: Analysis of a Global Patient Registry. J Infect Dis. 2010.
PubMed Abstract available
Keiner B, Maenz B, Wagner R, Cattoli G, et al.
Intracellular distribution of NS1 correlates with infectivity and interferon antagonism of an avian influenza virus (H7N1). J Virol. 2010.
PubMed Abstract available
Prabakaran M, He F, Meng T, Madhan S, et al.
Neutralizing epitopes of influenza virus hemagglutinin: Target for the development of universal vaccine against H5N1 lineages. J Virol. 2010.
PubMed Abstract available
Chutinimitkul S, Herfst S, Steel J, Lowen AC, et al.
Virulence-associated substitution D222G in hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol. 2010.
PubMed Abstract available
Brown JN, Palermo RE, Baskin CR, Gritsenko M, et al.
Macaque Proteome Response to Highly Pathogenic Avian Influenza and 1918 Reassortant Influenza Virus Infections. J Virol. 2010.
PubMed Abstract available
Liu WC, Lin SC, Yu YL, Chu CL, et al.
Dendritic Cell Activation by Recombinant Hemagglutinin Proteins of H1N1 and H5N1 Influenza A Viruses. J Virol. 2010.
PubMed Abstract available
Orozovic G, Latorre-Margalef N, Wahlgren J, Muradrasoli S, et al.
Degenerate primers for PCR amplification and sequencing of the avian influenza A neuraminidase gene. J Virol Methods. 2010.
PubMed Abstract available
Nukiwa N, Suzuki A, Furuse Y, Shimabukuro K, et al.
Simplified Screening Method for Detecting Oseltamivir Resistant Pandemic Influenza A (H1N1) 2009 Virus by a RT-PCR-Restriction Fragment Length Polymorphism Assay. J Virol Methods. 2010.
PubMed Abstract available
Nazir J, Haumacher R, Abbas MD, Marschang RE, et al.
Use of filter carrier technique to measure the persistence of avian influenza viruses in wet environmental conditions. J Virol Methods. 2010.
PubMed Abstract available
...
Parental Attitudes and Experiences During School Dismissals Related to 2009 Influenza A (H1N1) --- United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59:1131-4.
PubMed Abstract available
Ellebedy AH, Ducatez MF, Duan S, Stigger-Rosser E, et al.
Impact of prior seasonal influenza vaccination and infection on pandemic A(H1N1) influenza virus replication in ferrets. Vaccine. 2010.
PubMed Abstract available
Uscher-Pines L, Maurer J, Kellerman A, Harris KM, et al.
Healthy young and middle age adults: What will it take to vaccinate them for influenza? Vaccine. 2010.
PubMed Abstract available
Lim SH, Lee JH, Kim BC, Jung SU, et al.
Adverse reaction of influenza A (H1N1) 2009 virus vaccination in pregnant women and its effect on newborns. Vaccine. 2010.
PubMed Abstract available
Baxter R, Ray GT, Fireman BH.
Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine. 2010.
PubMed Abstract available
Surls J, Nazarov-Stoica C, Kehl M, Casares S, et al.
Differential effect of CD4(+)Foxp3(+) T-regulatory cells on the B and T helper cell responses to influenza virus vaccination. Vaccine. 2010.
PubMed Abstract available
...
Policy Statement--Recommendation for Mandatory Influenza Immunization of All Health Care Personnel. Pediatrics. 2010.
PubMed Abstract available
-
------
45-53.